Fulcrum Therapeutics
Utility Patents
Last updated:
List of all Fulcrum Therapeutics patents 2 in total
| Status | Patent |
|---|---|
Grant | Utility: Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Filling date: 8 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Filling date: 8 Sep 2025 Issue date: 21 Jan 2020 |
Showing 1 to 2 of 2 patents.